Leukemia, Lymphocytic, Chronic, B-CellLeukemia, LymphoidSurvival RatePrecursor Cell Lymphoblastic Leukemia-LymphomaLeukemiaLeukemia, Myeloid, AcuteCell SurvivalSurvival AnalysisDisease-Free SurvivalPrognosisTreatment OutcomeLeukemia, B-CellAntineoplastic Combined Chemotherapy ProtocolsAsparaginaseRetrospective StudiesLeukemic InfiltrationAntineoplastic AgentsVincristineLeukemia, Myelogenous, Chronic, BCR-ABL PositiveMethotrexateVidarabineLeukemia, T-CellTime FactorsRemission InductionPrecursor B-Cell Lymphoblastic Leukemia-LymphomaB-LymphocytesSurvivalLeukemia, Biphenotypic, AcuteBone MarrowCytarabineGraft SurvivalRemission, SpontaneousGene Expression Regulation, LeukemicKaplan-Meier EstimateLymphocytes, NullNeoplasm StagingFollow-Up Studies6-MercaptopurineLeukemia, ExperimentalImmunoglobulin Heavy ChainsLeukemia-Lymphoma, Adult T-CellLymphomaRecurrenceCyclophosphamideBurkitt LymphomaReceptors, Antigen, B-CellChlorambucilCombined Modality TherapyZAP-70 Protein-Tyrosine KinaseDNA, NeoplasmApoptosisLeukemia, Hairy CellKaryotypingRosette FormationPhiladelphia ChromosomeAntibodies, MonoclonalPrednisoneTumor Cells, CulturedChromosomes, Human, 6-12 and XAnisocoriaAcute DiseaseDrug Administration ScheduleProportional Hazards ModelsLymphocytesDrug Resistance, NeoplasmNeoplasm Recurrence, LocalAntigens, NeoplasmChromosome AberrationsDoxorubicinRisk FactorsT-LymphocytesMutationCell Line, TumorCorneal PerforationBlast CrisisNeoplasm ProteinsTranslocation, GeneticLeukemia, MyeloidCladribineSalvage TherapyLeukemia Virus, MurineBone Marrow TransplantationTumor Markers, BiologicalTransplantation, HomologousFusion Proteins, bcr-ablAntigens, CD5Antigens, CD38DNA NucleotidylexotransferaseDaunorubicinBase SequenceFlow CytometryAntibodies, Monoclonal, Murine-DerivedImmunoglobulin Variable RegionMultivariate AnalysisChromosomes, Human, Pair 14NeprilysinMolecular Sequence DataDisease ProgressionProto-Oncogene ProteinsActuarial Analysis